Description
| Product Name | CAT.No | Size |
| Helicobacter Pylori, IgA | BXE0672A | 96T |
| Helicobacter Pylori, IgG | BXE0673A | 96T |
| Helicobacter Pylori, IgM | BXE0674A | 96T |
Product Description
The Biorex Diagnostics Helicobacter pylori ELISA kits are highly sensitive and specific microplate enzyme-linked immunosorbent assays (ELISA) designed for the quantitative measurement of IgA, IgG, and IgM antibodies against H. pylori in human serum or plasma. H. pylori is a spiral-shaped, gram-negative bacterium that colonises the gastric mucosa and is strongly associated with chronic gastritis, peptic ulcer disease, and an elevated risk of gastric cancer. Accurate assessment of antibody levels enables clinicians to diagnose active and past infections, monitor response to eradication therapy, and support epidemiological studies. Early and reliable detection is critical for guiding treatment decisions, preventing disease progression, and reducing the risk of severe gastrointestinal complications.
Key Features
- Quantitative Microplate ELISA – enables precise and reproducible measurement of IgA, IgG, and IgM antibodies against H. pylori
- High Sensitivity and Specificity – detects physiologically and clinically relevant antibody concentrations, minimising false positives and negatives
- Serum and Plasma Compatibility – validated for routine clinical samples, facilitating flexible laboratory workflows
- Reproducible Results – ensures consistent performance across multiple assays and operators
- Comprehensive Kit Components – includes ready-to-use reagents, pre-formulated standards, and controls for streamlined testing
- Clinical and Research Utility – supports diagnosis, therapy monitoring, epidemiological surveys, and research into infection-related gastrointestinal disorders
The Biorex Diagnostics Helicobacter pylori ELISA kits provide a trusted, efficient, and clinically relevant solution for laboratories and healthcare providers worldwide. By enabling accurate quantitative measurement of antibodies against H. pylori, these assays support reliable diagnosis, effective monitoring of eradication therapy, and research into the pathophysiology of gastric infections. Their robust performance and reproducibility contribute to informed clinical decision-making, improved patient outcomes, and enhanced understanding of infection prevalence in populations, making them a valuable tool for both clinical and research applications in gastrointestinal health.
Contact Us for more information.